๐งฌ Ozempic's Active Ingredient Slows Biological Aging by 9% in First Human Randomized Trial
A study published in Nature Communications found semaglutide โ the active ingredient in Ozempic and Wegovy โ reduced the speed of biological aging by about 9% in a 32-week randomized controlled trial of adults with HIV. Epigenetic clock measurements showed improvements across markers tied to the brain, heart, liver, kidneys, and metabolic health. It's the first randomized human trial to show a GLP-1 drug may influence how fast we age biologically, though researchers stress larger studies are still needed. Could weight-loss drugs eventually become mainstream anti-aging medicine?